Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19
Manuja Gunasena(The Ohio State University), Namal P. M. Liyanage(National Cancer Institute), Jeffrey C. Horowitz(Lung Institute), Nicholas Funderburg(Ohio Department of Health), Thorsten Demberg(Baylor College of Medicine), Yasasvi Wijewantha(The Ohio State University), Janelle Gabriel(The Ohio State University), Emily Bowman(The Ohio State University), Scott Scrape(The Ohio State University), Krishanthi Weragalaarachchi(The Ohio State University), Anna E. Vilgelm(The Ohio State University), Shan‐Lu Liu(The Ohio State University), Amrendra Kumar(University of Delhi), Sonal Pannu(Oklahoma City University), Dhanuja Kasturiratna(Northern Kentucky University), Saranga Wijeratne(Nationwide Children's Hospital), Aaren Kettelhut(The Ohio State University), Mario Alles(The Ohio State University), Will Mulhern(The Ohio State University), Joseph S. Bednash(The Ohio State University Wexner Medical Center)
Cited by 6
Related Papers
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|580
Microbial translocation, immune activation, and HIV disease
|Trends in Microbiology|2012|393
IFITM Proteins Restrict Viral Membrane Hemifusion
|PLoS Pathogens|2013|370
Extracellular matrix in lung development, homeostasis and disease
|Matrix Biology|2018|290